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Summary
The biochemical mechanisms by which octopamine, catecholamines and the
peptide proctolin exert their actions on Limulus cardiac muscle were investigated.
Amines produced long-lasting increases in the amplitude of contractions evoked
by electrical stimulation. At 10~5moll~1, the apparent order of potency for
amine-induced increases in evoked contraction amplitude was dopamine =
octopamine >norepinephrinei=epinephrine. At this dose, amines produced
long-lasting increases in the levels of cyclic AMP (octopamine > dopamine »
norepinephrine==epinephrine), but not of cyclic GMP, in Limulus cardiac
muscle.
Like the amines, the adenylate cyclase activator forskolin enhanced cardiac
muscle contractility and increased levels of cyclic AMP, but not of cyclic GMP.
The phosphodiesterase inhibitor IBMX produced a transient increase in cardiac
muscle contractility, but typically produced long-lasting negative inotropy. This
agent increased levels of both cyclic AMP and cyclic GMP in Limulus cardiac
muscle.
Proctolin and the protein kinase C activator phorbol dB increased the
contraction amplitude of the intact heart and the electrically stimulated myocar-
dium. These compounds, as well as dopamine, elicited sustained contractures and
rhythmic contractions when applied to deganglionated Limulus cardiac muscle
rings. Unlike the amines, proctolin and phorbol dB did not increase cardiac
muscle cyclic AMP levels.
These results suggest that several second-messenger systems may be utilized by
amines and peptides to produce excitatory actions on cardiac muscle fibers of the
Limulus heart. Cyclic AMP appears to be an important second messenger
underlying the effects of amines to enhance cardiac muscle contractility. Pharma-
cological data suggest that proctolin may alter cardiac muscle contractility and
excitability by a mechanism which involves the phosphatidylinositol pathway.
Dopamine, unlike the other amines, produces a number of proctolin-like effects
and may activate both the cyclic AMP and the phosphatidylinositol systems in
Limulus cardiac muscle.
•Present address: Biology Department, Utah State University, Logan, UT 84322, USA.
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Introduction
The neurogenic heart of the horseshoe crab Limulus polyphemus is modulated
by a number of amines and peptides present in the nervous system of this animal
(for a review, see Watson & Augustine, 1982). Amines, which include octopamine
(OCT), dopamine (DA), norepinephrine (NE) and epinephrine (EPI), act on
multiple cellular targets within the cardiac ganglion/cardiac muscle network to
produce increases in both the rate and the strength of heart contractions. Heart
rate is increased by aminergic actions on pacemaker neurons in the cardiac
ganglion (Augustine etal. 1982; Augustine & Fetterer, 1985); and the strength of
heart contractions is enhanced through presynaptic actions on the neuromuscular
junction to increase transmitter release (Watson & Hoshi, 1981) and postsynaptic
actions to increase cardiac muscle contractility (Watson et al. 1985).
The excitatory actions of the amines on Limulus heart involve cyclic AMP as a
second messenger (Groome & Watson, 1987). Amines increase the concentration
of cyclic AMP, but not of cyclic GMP, in the Limulus cardiac ganglion and in
cardiac muscle. Drugs which cause increases in intracellular levels of cyclic AMP,
such as forskolin and 3-isobutyl 1-methyl xanthine (EBMX), have effects on the
intact heart which are similar to those produced by the amines. In this study we
investigated the role of cyclic AMP as a second messenger mediating the inotropic
actions of amines on cardiac muscle.
Like the amines, the peptide proctolin and a proctolin-like peptide partially
purified from Limulus nervous tissue produce increases in the strength of heart
contractions (Benson et al. 1981). Proctolin produces its inotropic actions by
enhancing cardiac muscle contractility (Watson etal. 1983). It also induces
rhythmic contractions in the normally quiescent deganglionated Limulus heart
(Watson & Hoshi, 1985). The biochemical mechanisms underlying these inotropic
and myogenic effects have not been investigated in Limulus.
In this paper we present evidence indicating that most, but not all, of the actions
of amines on Limulus cardiac muscle involve cyclic AMP as a second messenger.
Additionally, proctolin and, to some extent, dopamine may act on cardiac muscle
through a second-messenger system involving protein kinase C. Therefore,
peptide and amine modulation of cardiac muscle contractility in Limulus involves
at least two second-messenger systems.
Materials and methods
Measurement of cardiac muscle contractility
The contraction amplitude of intact Limulus hearts was monitored as described
previously (Groome & Watson, 1987). To examine the direct effect of various
compounds on cardiac muscle contractility, cardiac muscle rings (1-2 cm) were
excised from deganglionated hearts and contractions were evoked by electrical
stimulation. One lateral edge of each muscle ring was pinned to the bottom of a
20 ml stimulation chamber. A steel pin was inserted through the lumen of the ring
and attached by a thread to a force transducer (Grass FT.03C). Contractions were
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evoked by passing current (1-2 V, 80 ms duration at 0-1-0-2 Hz) between vertical
stainless-steel plate electrodes located 2 mm from either side of the myocardial
ring. Test solutions were added via the perfusion reservoir. To examine the effect
of compounds on cardiac muscle fiber excitability in the absence of neuronal or
electrical stimulation, tension was recorded from deganglionated myocardial rings
pinned out in 5 ml perfusion chambers. Preparations were perfused continuously
1) with sea water at room temperature.
Radioimmunoassay for cyclic nucleotides
The tissue extraction and radioimmunoassay (RIA) protocols for Limulus
tissues have been described previously (Groome & Watson, 1987). Briefly, cardiac
muscle rings were incubated in test solutions, homogenized in 6 % trichloroacetic
acid and centrifuged (10 000 g for 30min at 0°C). The supernatants were extracted
in diethyl ether and dried. Cyclic AMP and cyclic GMP levels in cardiac muscle
extracts were then determined by RIA. The tissue pellet from each homogenate
was boiled in lmoll~1NaOH for determination of protein content (Lowry etal.
1951).
Solutions
Natural sea water or artificial Limulus saline was used in these experiments.
Normal Limulus saline was of the following composition: 445mmoll~1 NaCl,
n r a m o i r 1 KC1, lOmmoll"1 CaCl2, 46mmoll"1 MgCl2, with lOmmoll"1 Hepes
buffer at pH7-5. Zero-calcium saline was made by omitting CaCl2 and adding
2mmoll~1 EGTA. Pharmacological agents utilized in this study were obtained
from the following sources: 3-hydroxytyramine hydrochloride (dopamine, DA),
(-)adrenalin (epinephrine, EPI) 3-isobutyl 1-methyl xanthine (IBMX), ( - ) -
arterenol (norepinephrine, NE), DL-octopamine (OCT), l-oleyl-2-acetyl sn-
glycerol, papaverine, phorbol 12,13-dibutyrate (phorbol dB), phorbol 12-myr-
istate 13-acetate (Sigma Chemical Co., St Louis, Missouri); forskolin (Calbio-
chem, San Diego, California); proctolin (Peninsula Laboratories, Belmont,
California); RO-20-1724 (a gift from Hoffman LaRoche, Nutley, New Jersey); SQ
20009 (Squibb, Princeton, New Jersey).
Drug solutions were made either by dissolving agents directly in sea water, or by
adding a sample of a stock drug solution to sea water. Carriers for stock solutions
were: 0-1 moll"1 acetic acid for amines, 95% ethyl alcohol for forskolin, 100%
dimethyl sulfoxide for RO-20-1724 and distilled water for others. All stocks were
diluted 5=1000 times. Control experiments indicated that these carrier concen-
trations did not affect the contractile or electrical properties of cardiac muscle
fibers.
Results
Amine effects on electrically evoked contractions of cardiac muscle
Direct effects of amines on cardiac muscle contractility are difficult to quantify







Fig. 1. Amines, at 10 5moll 1, increased the amplitude of contractions of degangli-
onated cardiac muscle rings stimulated by electrical current pulses of constant
frequency. Amines were added at the arrow and continuously perfused over the
preparation. Responses to dopamine or octopamine were more rapid in onset and
larger in magnitude than to either norepinephrine or epinephrine.
using the intact Limulus heart preparation, since amine-induced increases in heart
rate decrease their overall inotropic action (Watson etal. 1985). Therefore, to
assess the excitatory effect of amines on cardiac muscle contractility, degangli-
onated myocardial rings were prepared and contractions were evoked by electrical
stimulation. All the amines tested, at 10~5 mol I"1, produced a gradual increase in
the amplitude of evoked heart contractions (Fig. 1, Table 1). Both DA and OCT
had greater effects than either NE or EPI at this dose. The enhancement of evoked
heart contraction amplitude by DA and OCT was particularly long-lasting
(Fig. 2A). Contractions typically continued to increase in size for at least 15min
after removal of amine from the bath and only gradually declined to control
amplitude after 1-2 h.
Amine effects on levels of cyclic nucleotides in cardiac muscle
Levels of cyclic AMP in Limulus cardiac muscle were elevated by all the amines
tested, at 10~5molP1 (Table 1). At this dose, OCT had a significantly greater
effect on cardiac muscle cyclic AMP levels than any of the other amines tested,
producing a 795-1% (±139-8S.E.M.) increase in cyclic AMP content. Amine-
induced increases in cardiac muscle cyclic AMP content were long-lasting,
persisting for at least 20min after removal of amine from the incubation solution
(Fig. 2B). None of the amines increased cyclic GMP levels in Limulus cardiaq
muscle (Table 1). Removal of calcium from the incubation medium did not reduce
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Table 1. Physiological and biochemical effects of amines and pharmacological agents on
Limulus cardiac muscle
Agent




































659-6 ± 135-4 (14)t
680-7 ± 163-0 (18)t
227-7 ± 53-7 (12)t
217-6 ±99-9 (12)*































































The mean (±S.E.M.) of N experiments (shown in parentheses) is represented for measurements of
peak physiological effect (for IB MX both positive and negative values are given), and for
radioimmunoassay measurements obtained after exposure of cardiac muscle rings to these agents for
lOmin.
Level of significant difference from control was determined by a Student's Mest.
Level of significance: t(P=S0-02); *(/>=£ 0-05).
OCT, octopamine; DA, dopamine; NE, norepinephrine; EPI, epinephrine; IBMX, 3-isobutyl
1-methyl xanthine; phorbol dB; phorbol 12,13-dibutyrate.
the effect of amines on cyclic AMP levels in Limulus cardiac muscle. At
l O ^ m o i r 1 , both DA (255-0% ±23-1 S.E.M., TV = 6) and OCT (681-4% ±51-3
S.E.M., N=6) produced increases in cardiac muscle cyclic AMP after 3min that
were significant and comparable to increases observed when calcium was present.
The increases in cardiac muscle cyclic AMP levels induced by OCT or DA were
dose-dependent (Fig. 3A). Octopamine increased levels of cardiac muscle cyclic
AMP to a larger extent than did DA at all doses tested (10~6 to S x K T ' m o i r 1 ) .
Neither OCT nor DA altered cardiac muscle cyclic GMP content at any dose
(Fig. 3B).
Effects of forskolin and IBMX
activator forskolin, at 5xlO~6n
and long-lasting increase in the size of evoked heart contractions (Fig. 4, Table 1).
The adenylate cyclase 10 6mol 1 \ induced a gradual
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Fig. 2. (A) Dopamine (10 5moll l) and octopamine (10 5moll x) produced similar
long-lasting increases in the size of electrically evoked contractions of deganglionated
cardiac muscle. Amines were added for 10 min, indicated by the solid line, and
contractions continued to increase for approximately 20 min after removal of amine
from the perfusion solution. Each point represents the mean increase in contraction
amplitude ± S.E.M. in 14-18 experiments. (B) Both amines (MT'moll"1) elevated
cardiac muscle cyclic AMP levels with a time course similar to their inotropic effect.
However, the relative magnitude of the cyclic AMP increase for octopamine is much
greater than that for dopamine. Each point represents the mean content of cardiac
muscle cyclic AMP (±S.E.M.) in 6-7 experiments.



















- 5 0 ' - 4 0 - 6 0
log amine concentration (moll"1)
- 5 0
Fig. 3. Dose-response curve for amine effects on levels of cyclic nucleotides in
Limulus cardiac muscle. Tests were performed by incubating cardiac muscle rings in
various doses of octopamine or dopamine for 3 min. (A) Octopamine produced greater
increases in cardiac muscle cyclic AMP than did dopamine at all doses above
10"6moll~1. (B) Neither octopamine nor dopamine, at any dose, influenced cardiac
muscle cyclic GMP levels in these experiments. In both A and B, each point represents
the mean content of cardiac muscle cyclic AMP or cyclic GMP (±S.E.M.) in five
experiments.
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Fig. 4. Effect of forskolin (5xlO~6moH~1) and IBMX (lO^moir1) on evoked
contractions in Limulus cardiac muscle rings. (A) Records of contractions before and
30min after initial addition of agent to the preparation. (B) The effects of forskolin
and IBMX (added for 15 min; solid line) on evoked contractions were long-lasting.
Each point represents the mean change in amplitude ± S.E.M. in 14-15 experiments.
Enhancement of contraction amplitude was not blocked by pretreatment of the
preparation with 3x 10~7 mol I"1 tetrodotoxin (TTX). Since TTX appears to block
residual or electrically evoked neuronal activity in this preparation (Watson et al.
1985), this result suggests a direct, amine-like effect of forskolin upon cardiac
muscle fibers to increase contractility. At 5xlO~6moll~1, forskolin also increased
levels of cardiac muscle cyclic AMP, but not of cyclic GMP (Table 1).
In contrast to the positive inotropic effect of forskolin, the phosphodiesterase
inhibitor IBMX (10~3moir1) consistently decreased the amplitude of evoked
contractions (Fig. 4, Table 1). The effect of IBMX was long-lasting and TTX-
insensitive. However, in six of 14 experiments, IBMX elicited a transient increase
in contraction amplitude prior to the onset of inhibition. IBMX, at 10~3moir1 ,
significantly elevated levels of both cyclic AMP and cyclic GMP in cardiac muscle
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(Table 1). The percentage increase in cardiac muscle cyclic GMP elicited by EBMX
(292-3 % ± 74-4 S.E.M.) was much greater than the corresponding increase in cyclic
AMP (73-8 % ± 3-6 S.E.M.) in this tissue. Other phosphodiesterase inhibitors, such
as papaverine ( lO^moll"1) , SQ 20009 ( lO^molP 1 ) , and RO-20-1724
(10~3moll~1), had lesser positive inotropic effects and negligible effects on levels
of cardiac muscle cyclic AMP (Table 1).
Proctolin and phorbol dB actions on cardiac muscle contractions
Like the amines, the peptide proctolin increases the strength of heart contrac-
tions, but has a minimal effect on heart rate (Benson etal. 1981). The protein
kinase C activator phorbol dB, at 3x 10~7molP1, mimicked the positive inotropic
action of 10~7moir1 proctolin on the intact Limulus heart (Fig. 5). Both phorbol
dB and proctolin produced a comparable increase in contraction amplitude, but
the effect of the phorbol ester was slower in onset and in decay. In most
experiments, the effects of proctolin and phorbol dB were exclusively inotropic,
although occasionally these agents did produce slight increases in heart rate.
The inotropic effect of proctolin and phorbol dB was the result of an alteration
in the properties of cardiac muscle fibers, since these agents also produced long-
lasting increases in the amplitude of electrically evoked contractions of deganglio-
nated myocardial rings (Fig. 6). The effect of neither agent was altered by
pretreatment of the preparation with 3xlO~ 7 moir x TTX.
Phorbol 12-myristate 13-acetate and 1-oleyl 2-acetyl sn-glycerol were much less
effective than phorbol dB in increasing the amplitude of cardiac muscle contrac-
tions. These agents produced only slight inotropic effects, and only at relatively
high doses ^ ^ 1
Effects of proctolin and phorbol dB on cyclic nucleotide levels in cardiac muscle
Levels of cyclic AMP or cyclic GMP in deganglionated cardiac muscle rings
were not altered by a lOmin incubation in proctolin at 10~6-10~5moll~1
(Table 1). Additionally, incubation of cardiac muscle rings in 10~6moll~1 procto-
lin solutions for periods ranging from 30s to lOmin did not result in transient
increases in levels of cyclic AMP or cyclic GMP. Like proctolin, phorbol dB
(3xlO~7moll~1) had no effect on levels of cyclic AMP in cardiac muscle rings
incubated in this drug for 10 or 20min (Table 1).
Additional effects of proctolin, amines and pharmacological agents on Limulus
cardiac muscle
Sustained contractures of cardiac muscle rings were often observed during
application of 10~7moll~1 proctolin to preparations stimulated by electrical
current pulses (Fig. 7). In several experiments DA, at 10~5moll"1, produced a
similar effect.
Proctolin, applied at a concentration of 10~6moll~1, produces both contracture
and rhythmic contractions in deganglionated Limulus hearts (Watson & Hoshi,
1985). In this study, similar effects were observed with the application of
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Fig. 5. Proctolin and the protein kinase C activator phorbol 12,13-dibutyrate (phorbol
dB) elicit positive inotropic, but not chronotropic, responses when applied to the intact
Limulus heart. (A) Record of heart contractions before and during peak response to
lCr'moll"1 proctolin or 3xlO~7moll~1 phorbol dB. (B) Time course of the inotropic
effect of proctolin or phorbol dB (added to the preparation as indicated by the solid
line).
10 6moll * proctolin to deganglionated 2 cm cardiac muscle rings (Fig. 8,
Table 2). Dopamine (lO^moll"1) and phorbol dB (5xlO" 7 moir 1 ) also elicited
contracture and rhythmic contractions in deganglionated cardiac muscle rings
(Fig. 8, Table 2). While the degree of contracture produced by phorbol dB was
less than that elicited by either proctolin or DA, the phorbol ester more
consistently produced rhythmic contractions than any agent tested. In contrast,
OCT (1CT5 mol I"1) produced a modest contracture in only one of 15 preparations.
Octopamine elicited rhythmic contractions in a few experiments, but these
contractions were of much smaller amplitude and lower frequency than DA-
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A Control Proctolin
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Fig. 6. The positive inotropic effects of proctolin and phorbol dB are the result of
direct actions on cardiac muscle fibers. (A) Record of electrically evoked cardiac
muscle contractions before and during peak response to 10~7molP' proctolin or
3xlO~7moll~1 phorbol dB. (B) Time course of the increase in evoked contraction
amplitude in response to proctolin or phorbol dB (solid line indicates application).
elicited contractions. Forskolin (10~5moll~1) also rarely produced either of these
effects.
Dependence on external calcium has previously been demonstrated for the
action of proctolin on the deganglionated Limulus heart (Watson & Hoshi, 1985).
In the present experiments, rhythmic contractions induced by the application of
10~ 6 moir 1 proctolin, lO^moU"1 DA or 5x lO" 7 moi r 1 phorbol dB were
abolished with the introduction of the calcium channel blocker Mn2+
(20mmoll~1) to the recording chamber. Five to ten minutes after removal of
Mn2+, rhythmic contractions were again apparent. Addition of 3xlO~7moll~1
TTX to these preparations did not abolish contractions. When cardiac muscle







Fig. 7. Proctolin (10 7moll J) or dopamine (10 5moll 1) often caused a sustained
contracture when applied (continuously, starting at arrow) to cardiac muscle rings
stimulated to contract by regular current pulses. The contractile effect of proctolin was
observed more frequently and was more pronounced than that of dopamine. The
bottom arrow points to a small after-contraction observed during application of




Fig. 8. Effect of proctolin, dopamine and phorbol dB on Limulus cardiac muscle
excitability. Agents were applied to deganglionated cardiac muscle rings at the arrow
and washed off after lOmin exposure. Proctolin (10~6moir1), dopamine
1-7 „(10 moll ) and phorbol dB (5x10 moll ) all produced rhythmic contractions of
cardiac muscle. These agents often produced contracture of the myocardium prior to
the initiation of contractions. The interruption in the bottom trace is equal to a 10 min
period.
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Agents were applied to the preparation for lOmin and then removed from the perfusion
solution. Appearance or absence of rhythmic contractions of cardiac muscle rings in response to
a given agent was noted and the overall percentage of preparations which responded positively is
represented. The frequency and magnitude of contractions observed in response to particular
agents were variable, but were most pronounced for proctolin, DA and phorbol dB.
The force of sustained contractures produced by a given agent prior to the onset of rhythmic
contractions is expressed as the mean increase in baseline tension ± S.E.M.
See Table 1 for an explanation of the abbreviations.
rings were perfused with saline containing 0Ca2+/2mmoll 1 EGTA, application
of proctolin, phorbol ester or DA was without effect. Subsequent washing of the
preparation with normal saline resulted in contracture and long-lasting rhythmic
contractions.
Discussion
Several second-messenger systems appear to be involved in the expression of
peptide and amine actions on Limulus cardiac muscle. The present study indicates
that cyclic AMP is an important second messenger of amine actions on cardiac
muscle contractility. While cyclic AMP may be the sole second messenger
underlying the inotropic actions of OCT, NE and EPI, DA may utilize both the
cyclic AMP and the phosphatidylinositol (Ptdlns) systems to enhance the strength
of heart contractions. Proctolin, which has no effect on cyclic nucleotide
metabolism in Limulus cardiac muscle, may produce its positive inotropic (and
myogenic) actions by a process involving the activation of protein kinase C. These
findings suggest that the biochemical basis for peptide and amine modulation of
cardiac muscle in Limulus consists of multiple second-messenger systems acting
either in concert, or separately, to produce characteristic cellular responses.
Role of cyclic AMP in amine actions on cardiac muscle contractility
Octopamine, NE and EPI increased the amplitude of electrically evoked
contractions of Limulus cardiac muscle with a potency and time course consistent
with their relative capacity to increase cardiac muscle cyclic AMP level. The
adenylate cyclase activator forskolin also enhanced cardiac muscle contractility.
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Although forskolin has been shown to produce effects in some systems by a non-
cyclic-AMP mechanism (Hoshi et al. 1988; Wagoner & Pallotta, 1988), we believe
that forskolin acts specifically on Limulus cardiac muscle fibers. Forskolin
significantly elevated levels of cyclic AMP, but not cyclic GMP, in Limulus cardiac
muscle. Additionally, forskolin has no effect on either the membrane potential or
the input resistance of Limulus cardiac muscle fibers (J. R. Groome & W. Watson,
unpublished results). Therefore, it appears that forskolin and the amines influence
the process of excitation-contraction coupling in the Limulus heart by increasing
cardiac muscle cyclic AMP level. The results from the present study are the first to
suggest a cyclic-AMP-dependent mechanism underlying a specific action of amines
to enhance cardiac muscle contractility in a neurogenic heart.
A cyclic-AMP-dependent mechanism appears to underlie the excitatory actions
of amines on excitation-contraction coupling in the myogenic hearts of Aplysia
(Sawada et al. 1984; Drummond et al. 1985) and Mercenaria (Higgins, 1974;
Paciotti & Higgins, 1985). In addition, octopamine may utilize cyclic AMP to
increase the contraction strength of the lobster heart (Battelle & Kravitz, 1978).
The involvement of cyclic AMP in the positive inotropic actions of amines has also
been documented for a wide variety of vertebrate species (Reuter, 1974; Tsien,
1977; Benfey, 1980; Kranias & Solaro, 1982; Earm et al. 1983; Macey etal. 1984).
These studies and the present results suggest a general messenger role for cyclic
AMP in amine modulation of cardiac muscle contractility.
Proctolin and cyclic nucleotides
Proctolin failed to stimulate cyclic AMP or cyclic GMP synthesis in Limulus
cardiac muscle at doses (10~6 and 10~5moll~1) which have profound effects on
cardiac muscle contractility. Additionally, proctolin did not elicit a transient
increase in either cyclic AMP or cyclic GMP level, as has been described in other
peptidergic systems (e.g. the action of SCPB in the Aplysia ventricle; Lloyd et al.
1985). These findings clearly indicate that proctolin does not increase cardiac
muscle contractility in Limulus via a mechanism dependent on cyclic AMP or
cyclic GMP.
Several previous studies have investigated the relationship between the actions
of proctolin (or a proctolin-like peptide) on smooth, skeletal and cardiac muscle of
arthropods, and the effects of this peptide on cyclic nucleotide metabolism
(S.-Rosza & Miller, 1980; Jennings etal. 1983; Evans, 1984a,6). In these and the
present studies, cyclic nucleotides were not shown to have a major role in the
actions of proctolin on invertebrate muscle.
Possible second messengers underlying the effects of proctolin on Limulus
cardiac muscle
The mechanism by which proctolin increases contractility in Limulus cardiac
muscle may involve activation of protein kinase C. Several of the effects of
proctolin and phorbol dB (which mimics the stimulatory action of diacylglycerol
on protein kinase C) were similar in two separate preparations (intact heart and
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electrically stimulated myocardium). First, both proctolin and phorbol dB
increased the amplitude of contractions in these preparations. Second, these
effects were long-lasting. Finally, neither of these compounds significantly altered
heart rate, as do the amines.
Stimulation of the PI system involves the production of inositol trisphosphate
(InsP3) and diacylglycerol (DAG) as second messengers (Berridge & Irvine,
1984). Inositol trisphosphate causes the release of internal calcium from the
sarcoplasmic reticulum in invertebrate (Rojas et al. 1987; Tublitz & Trombley,
1987) and vertebrate muscle (Streb et al. 1983; Somlyo et al. 1985; Vergara et al.
1985; Nosek et al. 1986). Phorbol esters mimic the protein kinase C stimulating
action of DAG in many cells (Kishimoto et al. 1980; Castagna et al. 1982). Phorbol
esters also increase muscle contractility in some systems (Sybertz et al. 1986; Dale
& Obianime, 1987; Itoh & Lederis, 1987). In locust skeletal muscle, proctolin may
increase levels of inositol trisphosphate and enhances contractions induced by
glutamate (Worden & O'Shea, 1986). While protolin may utilize the Ptdlns system
in its inotropic actions in the Limulus heart, further studies are needed to
determine the relationship between stimulation of the Ptdlns system by proctolin,
protein kinase C activation and inotropic modulation.
Activation of protein kinase C in many systems is closely tied to calcium
movements within the cell or across the cells membrane (for a review, see Berridge
& Irvine, 1984). In the present study, experiments with proctolin and phorbol dB
on deganglionated heart muscle suggest that protein kinase C may be important in
several actions of proctolin which are dependent on calcium. First, proctolin and
the phorbol ester elicited prolonged, calcium-dependent contractures in Limulus
cardiac muscle. Calcium-dependence has been noted for the postsynaptic action of
proctolin on skeletal muscle fibers in Limulus (Rane et al. 1984) and Homarus
(Schwarz et al. 1980). A second calcium-dependent effect of proctolin or phorbol
dB on Limulus cardiac muscle was the production of rhythmic contractions in the
absence of neuronal input. Sensitivity to calcium channel blockers, but not to
TTX, suggests a similar pharmacological profile of contractions induced by either
proctolin or phorbol dB. Contractions produced by proctolin are associated with
10-20 mV spikes (Watson & Hoshi, 1985). Intracellular recordings from phorbol-
treated cardiac muscle also reveal 10-15 mV spike-like potentials concomitant
with contractions (J. R. Groome & W. H. Watson, unpublished results). These
pharmacological results point out the necessity to determine the second messen-
gers produced in Limulus cardiac muscle in response to proctolin. Biochemical
studies may establish the specific role(s) for protein kinase C in the modulation of
contractile and electrical properties of cardiac muscle fibers by proctolin.
Dopaminergic activation of multiple second-messenger systems in cardiac muscle
Dopamine significantly increased cyclic AMP levels in cardiac muscle with a
time course similar to its effect on cardiac muscle contractility. However, in
comparison with the other amines, DA had an excitatory inotropic effect which
was disproportionate with its capacity to elevate cardiac muscle cyclic AMP level
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(Table 1, Fig. 2). This discrepancy does not appear to be simply a consequence of
excess cyclic AMP production (and thus an oversaturation of protein kinase A) by
OCT. This hypothesis is supported by the observation that there was no significant
difference in elevation of cardiac muscle cyclic AMP level by DA, NE or EPI,
while the effect of DA on evoked contractions was much greater than that of either
NE or EPI. Therefore, the overall inotropic effect of DA must involve some other
mechanism, in addition to activation of protein kinase A.
The similarity in effect of proctolin, phorbol ester and DA on several
preparations suggests that both DA and proctolin may activate protein kinase C in
Limulus cardiac muscle. All these agents elicited contracture and rhythmic
contractions of deganglionated cardiac muscle. Interestingly, DA has been shown
to produce myogenic activity in deganglionated Limulus cardiac muscle during
glutamate-induced contractions (Watson et al. 1985). Increased cardiac muscle
contractility and excitability in response to DA may involve activation of cardiac
muscle DA receptors linked to the Ptdlns/protein kinase C messenger system as
well as cardiac muscle DA receptors linked to the cyclic AMP/protein kinase A
messenger system.
Cyclic AMP and cyclic GMP as opposing regulators of heart contraction strength
Cyclic GMP is not involved in excitatory actions of amines or proctolin on
Limulus cardiac muscle. Rather, increases in cyclic GMP level may oppose the
excitatory influences of cyclic AMP on cardiac muscle contractility. The phospho-
diesterase inhibitor IB MX increased levels of both cyclic AMP and cyclic GMP in
Limulus cardiac muscle (Table 1). It is possible that the biphasic inotropic
response of the Limulus heart to IBMX (see Groome & Watson, 1987) is a
consequence of the biochemical effect of IBMX on both cyclic AMP and cyclic
GMP content of cardiac muscle. IBMX only transiently enhanced the strength of
evoked contractions. This response was followed by prolonged inhibition. Positive
inotropy in response to IBMX may be a consequence of increased levels of cardiac
muscle cyclic AMP, while the negative inotropic effects of this compound may be a
result of increased levels of cyclic GMP. It has been proposed that increased levels
of muscle cyclic GMP might oppose the stimulatory effects of cyclic AMP on the
myogenic rhythm in the extensor tibiae muscle of the locust Schistocerca, where
millimolar concentrations of IB MX increase levels of both cyclic AMP and cyclic
GMP (Evans, 1984a).
Recently, we have investigated the actions of a Limulus FMRFamide-like
peptide (as yet unpurified) on the Limulus heart. This peptide, tentatively named
limadrin (White & Watson, 1984), also produces a biphasic inotropic effect on the
Limulus heartbeat and increases both cyclic AMP and cyclic GMP levels in cardiac
muscle (Groome, 1988). The similarity of IBMX and limadrin actions on the
physiology and biochemistry of Limulus cardiac muscle raises the possibility that
cyclic GMP, like cyclic AMP, may be important in the neurohormonal regulation
of cardiac muscle contractility.
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Role of cardiac muscle cyclic AMP phosphodiesterase
A negative inotropic effect is sometimes observed during bath application of
amines to the isolated, intact Limulus heart (Watson etal. 1985). This effect
appears to be a consequence of increased heart rate, and not a direct, negative
effect of amines on cardiac muscle contractility. Since cyclic AMP is important in
excitatory chronotropic as well as inotropic actions of amines on the Limulus heart
(Groome & Watson, 1987), the relative activities of cardiac ganglion and cardiac
muscle cyclic AMP phosphodiesterases may be important in the fine tuning of
simultaneous modulation of heart contraction rate and strength by amines.
Cyclic AMP elevation (and contractility increases) may be maximized in
Limulus cardiac muscle by a weak cyclic-AMP-dependent phosphodiesterase,
thereby partially offsetting the negative effects of increased rate. Cyclic AMP
produced in cardiac muscle transiently exposed to amine was only slowly degraded
to the inactive 5'-AMP metabolite. Contractility increases were likewise long-
lasting. Additionally, IBMX is ineffective in potentiating the effects of sub-
threshold doses of DA or OCT on heart contraction amplitude (Groome &
Watson, 1987) or levels of cardiac muscle cyclic AMP (Groome, 1988).
Although SQ 20009 and, to some extent, RO-20-1724 increased evoked
contraction amplitude, their biochemical actions are uncertain. For example, SQ
20009 produces marked irregularity in contractions of the intact Limulus heart
preparation (Groome & Watson, 1987), unlike the amines or other pharmacologi-
cal agents. In general, the phosphodiesterase inhibitors employed had minor
effects on cardiac muscle cyclic AMP levels, suggesting that this enzyme does not
effectively limit cyclic-AMP-dependent increases in contraction amplitude pro-
duced by the amines.
Amine-induced rate increases, however, may be limited by a highly active
cyclic-AMP-dependent phosphodiesterase in the cardiac ganglion (Groome,
1988). Amines and pharmacological agents produce increases in the cyclic AMP
content and burst rate of isolated Limulus cardiac ganglia which are of shorter
duration than those observed in cardiac muscle. Additionally, IBMX potentiates
the effects of subthreshold doses of DA or OCT to increase heart rate (Groome &
Watson, 1987) or to elevate cardiac ganglion cyclic AMP levels (Groome, 1988).
These findings suggest that a balance between the excitatory effects of amines on
specific cellular targets in this system might be achieved by the relative activities of
cardiac ganglion and cardiac muscle cyclic-AMP-dependent phosphodiesterases.
In summary, similar inotropic actions of amines and the peptide proctolin on the
neurogenic Limulus heart may be achieved by activation of the protein kinase A
system, the protein kinase C system, or both. Therefore, the Limulus myocardium
represents a promising system for investigating the interactions between two
classes of cardioregulatory agents and intracellular messenger systems. Finally, it
will be interesting to discover the degree to which these second-messenger systems
interact at other loci in the neurogenic Limulus heart network and to determine
the molecular basis underlying the overall effects of these neurohormones on the
cardiac rhythm.
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